Complement Factor H Polymorphism and Age-Related Macular Degeneration
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is a common, late-onset, and complex trait with multiple risk factors. Concentrating on a region harboring a locus for AMD on 1q25-31, the ARMD1 locus, we tested single-nucleotide polymorphisms for association with AMD in two independent case-control populations. Significant association ( P = 4.95 × 10 -10 ) was identified within the regulation of complement activation locus and was centered over a tyrosine-402 → histidine-402 protein polymorphism in the gene encoding complement factor H. Possession of at least one histidine at amino acid position 402 increased the risk of AMD 2.7-fold and may account for 50% of the attributable risk of AMD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A major AMD-associated SNP is the Y402H (tyrosine to histidine substitution at amino acid 402) variant of complement factor H (CFH) (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Edwards et al., 2005
In the citing paper
“These SNPs have been reported to be major genetic factors for developing AMD in Caucasians (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005; Tuo et al., 2006).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Edwards et al., 2005
In the citing paper
“Complement activation playing a major role in AMD pathogenesis is yet another source of inflammation [107-110].”
From Risk mitigation of immunogenicity: a key to personalized retinal gene therapy (2021) · cites this paper as [108]
In the citing paper
“Polymorphisms in human complement regulatory factor H (CFH) predispose individuals to AMD [35, 46, 59]”
From Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain (2022) · cites this paper as [35]
In the citing paper
“Genes in the complement pathway4–11 and a region of chromosome 10 12,13 have now been implicated as the major genetic contributors to disease.”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [4]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Haploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,525
Prevalence of Age-Related Macular Degeneration in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,736
Score Tests for Association between Traits and Haplotypes when Linkage Phase Is Ambiguous
Schaid, D. J., Rowland, C. M., Tines, D. E., Jacobson, R. M., & Poland, G. A. (2002) · The American Journal of Human Genetics · doi:10.1086/338688 · Cited by 1,783
The Five-year Incidence and Progression of Age-related Maculopathy
Klein, R., Klein, B. E. K., Jensen, S. C., & Meuer, S. M. (1997) · Ophthalmology · doi:10.1016/s0161-6420(97)30368-6 · Cited by 1,135
Mullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
The epidemiology of age-related macular degeneration
Klein, R., Peto, T., Bird, A., & Vannewkirk, M. R. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.069 · Cited by 932
Johnson, L. V., Leitner, W. P., Staples, M. K., & Anderson, D. H. (2001) · Experimental Eye Research · doi:10.1006/exer.2001.1094 · Cited by 621
Molecular Biology and Chemistry of the Alternative Pathway of Complement
Müller-Eberhard, H. J., & Schreiber, R. D. (1980) · Advances in Immunology · doi:10.1016/s0065-2776(08)60042-5 · Cited by 408
Seddon, J. M. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.6.785 · Cited by 398
Keenan, T. D., & Chew, E. Y. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.2210 · Cited by 377
Research works printed but not linked: 1
- M. H. Wener, P. R. Daum, G. M. McQuillan, J. Rheumatol.27, 2351 (2000).
Cited by
Items 901–1,000 of 1,021
C9-R95X Polymorphism in Patients with Neovascular Age-Related Macular Degeneration
Nishiguchi, K. M., Yasuma, T. R., Tomida, D., Nakamura, M., Ishikawa, K., Kikuchi, M., Ohmi, Y., Niwa, T., Hamajima, N., Furukawa, K., et al. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8425 · Cited by 51
Sohn, E. H., Wang, K., Thompson, S., Riker, M. J., Hoffmann, J. M., Stone, E. M., & Mullins, R. F. (2015) · Retina · doi:10.1097/iae.0000000000000263 · Cited by 46
“Moreover, single-nucleotide polymorphisms in ARMS2/ HTRA1 and CFH have been strongly associated with AMD when compared with controls.(6,7,18,19) However, homozygosity for high-risk alleles in either of these genes is not uniformly associated with progression from early to advanced AMD,(21,23) and genetic variation in…”
ResultNadeau, J. H., & Topol, E. J. (2006) · Nature Genetics · doi:10.1038/ng1006-1095 · Cited by 51
Vujosevic, S., Alovisi, C., & Chakravarthy, U. (2023) · Acta Ophthalmologica · doi:10.1111/aos.15767 · Cited by 49
“This allele causes over-activation of complement and disrupts the transport of oxidative lipids from the RPE layer as well as the regulatory function of CFH (Despriet et al., 2006; Edwards et al., 2005).”
BackgroundHakobyan, S., Tortajada, A., Harris, C. L., de Córdoba, S. R., & Morgan, B. P. (2010) · Kidney International · doi:10.1038/ki.2010.275 · Cited by 46
“The Y402H polymorphism of fH is strongly linked to age-related macular degeneration.(23) In Caucasians, the allele frequency (Y:H) is approximately 2.”
BackgroundClark, S., & Bishop, P. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm4010018 · Cited by 47
“results in a Y402H amino acid substitution in the FH protein [24-27], or at position 384 when using the mature protein sequence numbering [28] (see Figure 3A).”
MethodPlasma Biomarkers of Oxidative Stress and Genetic Variants in Age-Related Macular Degeneration
Brantley, M. A., Osborn, M. P., Sanders, B. J., Rezaei, K. A., Lu, P., Li, C., Milne, G. L., Cai, J., & Sternberg, P. (2011) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2011.08.033 · Cited by 53
Chromosome 10q26 locus and age-related macular degeneration: A progress update
Wang, G. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.11.009 · Cited by 48
Systems genetics for drug target discovery
Penrod, N. M., Sallari, R. C., & Moore, J. H. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.07.002 · Cited by 51
“The association between CFH and AMD was unexpected, yet it has been repeatedly observed [19, 20, 21].”
BackgroundSilva, A. S., Teixeira, A., Bavia, L., Lin, F. L. H., Velletri, R., Belfort, R., & Isaac, L. (2012) · PubMed Central · Cited by 56
Pei, X.-T., Li, X.-X., Bao, Y.-Z., Yu, W.-Z., Yan, Z., Qi, H.-J., Qian, T., & Xiao, H.-X. (2009) · Current Eye Research · doi:10.1080/02713680903003484 · Cited by 46
Liu, K., Chen, L. J., Tam, P. O. S., Shi, Y., Lai, T. Y. Y., Liu, D. T. L., Chiang, S. W. Y., Yang, M., Yang, Z., & Pang, C. P. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.10.003 · Cited by 49
Fisher, S. A., Rivera, A., Fritsche, L. G., Babadjanova, G., Petrov, S., & Weber, B. H. F. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.105577 · Cited by 46
Loyet, K. M., Good, J., Davancaze, T., Sturgeon, L., Wang, X., Yang, J., Le, K. N., Wong, M., Hass, P. E., Campagne, M. V. L., et al. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.215921 · Cited by 46
“Beyond its role in peripheral diseases, several lines of genetic and pathophysiologic evidence implicate overactivation of AP in AMD (Hageman et al., 2001; Johnson et al., 2001; Anderson et al., 2002, 2010; Edwards et al., 2005; Montezuma et al., 2007; Yates et al., 2007; Francis et al., 2009; Loyet et al., 2012; Ebra…”
BackgroundChen, S.-F., Wang, F., Li, Z., Yu, F., Chen, M., & Zhao, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00559 · Cited by 46
High-density lipoproteins are a potential therapeutic target for age-related macular degeneration
Kelly, U., Grigsby, D., Cady, M. A., Landowski, M., Skiba, N. P., Liu, J., Remaley, A. T., Klingeborn, M., & Rickman, C. B. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012305 · Cited by 49
“tyrosine (Y) to histidine (H) substitution at amino acid 402 (Y402H) in complement factor H (FH) (14-17).”
BackgroundDroho, S., Thomson, B. R., Makinde, H. M., Cuda, C. M., Perlman, H., & Lavine, J. A. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02010-0 · Cited by 51
Chu, J., Zhou, C., Lü, N., Zhang, X., & Dong, F.-T. (2008) · Chinese Medical Journal · doi:10.1097/00029330-200812020-00011 · Cited by 49
Brantley, M. A., Edelstein, S. L., King, J. M., Apte, R. S., Kymes, S. M., & Shiels, A. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.05.018 · Cited by 47
Gibbs, D., Yang, Z., Constantine, R., Ma, X., Camp, N. J., Yang, X. Q., Chen, H., Jorgenson, A., Hau, V. S., DeWan, A. T., et al. (2008) · Vision Research · doi:10.1016/j.visres.2007.10.022 · Cited by 51
The challenge of modeling macular degeneration in mice
Marmorstein, A. D., & Marmorstein, L. Y. (2007) · Trends in Genetics · doi:10.1016/j.tig.2007.03.001 · Cited by 53
The role of CRP and inflammation in the pathogenesis of age-related macular degeneration
Čolak, E., Majkić‐Singh, N., Zoric, L. D., Radosavljević, A., & Kosanović-Jaković, N. (2012) · Biochemia Medica · doi:10.11613/bm.2012.005 · Cited by 53
“Recently, a strong association between the Y402H single-nucleotide polymorphism in the complement factor H (CFH) gene and AMD was found in 3 clinic-based case control studies (59), and in a longitudinal population based study (60).”
BackgroundFernando, A. N., Furtado, P. B., Clark, S. J., Gilbert, H. E., Day, A. J., Sim, R. B., & Perkins, S. J. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.02.038 · Cited by 49
Angiogenesis in eye disease: immunity gained or immunity lost?
Ferguson, T. A., & Apte, R. S. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0113-8 · Cited by 47
Complement Factor H Polymorphism in Age-Related Macular Degeneration
Narayanan, R., Butani, V., Boyer, D. S., Atilano, S. R., Resende, G. P., Kim, D. S., Chakrabarti, S., Kuppermann, B. D., Khatibi, N. H., Chwa, M., et al. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.10.035 · Cited by 50
Kaur, I., Ghanekar, Y., & Chakrabarti, S. (2008) · International Journal of Human Genetics · doi:10.1080/09723757.2008.11886028 · Cited by 46
High Myopia Is Not Associated with the SNPs in the TGIF , Lumican, TGFB1 , and HGF Genes
Wang, P., Li, S., Xiao, X., Jia, X., Jiao, X., Guo, X., & Zhang, Q. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2537 · Cited by 50
Pauly, D., Nagel, B. M., Reinders, J., Killian, T., Wulf, M., Ackermann, S., Ehrenstein, B. P., Zipfel, P. F., Skerka, C., & Weber, B. H. F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096371 · Cited by 50
Imai, D., Mori, K., Horie‐Inoue, K., Gehlbach, P. L., Awata, T., Inoue, S., & Yoneya, S. (2010) · Journal of ocular biology, diseases, and informatics · doi:10.1007/s12177-010-9055-1 · Cited by 53
Calaza, K. D. C., Kam, J. H., Hogg, C. R., & Jeffery, G. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.06.010 · Cited by 45
Chowers, I., Cohen, Y., Goldenberg‐Cohen, N., Vicuna-kojchen, J., Lichtinger, A. D., Weinstein, O., Pollack, A., Axer‐Siegel, R., Hemo, I., Averbukh, E., et al. (2008) · PubMed Central · Cited by 49
A Recessive Gene for Primary Vesicoureteral Reflux Maps to Chromosome 12p11-q13
Weng, P. L., Sanna‐Cherchi, S., Hensle, T. W., Shapiro, E., Werzberger, A., Caridi, G., Izzi, C., Konka, A., Reese, A. C., Cheng, R., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008111199 · Cited by 45
Benasutti, H., Wang, G., Vu, V. P., Scheinman, R. I., Groman, E., Saba, L. M., & Simberg, D. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00496 · Cited by 45
Prevalence of common disease-associated variants in Asian Indians
Pemberton, T. J., Mehta, N. U., Witonsky, D., Rienzo, A. D., Allayee, H., Conti, D. V., & Patel, P. I. (2008) · BMC Genetics · doi:10.1186/1471-2156-9-13 · Cited by 51
“37989T>C Y402H rs1061170 Age-related macular degeneration [105-107]”
Xing, C., Sivakumaran, T. A., Wang, J. J., Rochtchina, E., Joshi, T., Smith, W. T., Mitchell, P., & Iyengar, S. K. (2008) · Genes and Immunity · doi:10.1038/gene.2008.10 · Cited by 47
Amyloidosis in Retinal Neurodegenerative Diseases
Masuzzo, A., Dinet, V., Cavanagh, C., Mascarelli, F., & Krantic, S. M. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00127 · Cited by 51
Molecular genetics of addiction vulnerability
Uhl, G. R. (2006) · NeuroRx · doi:10.1016/j.nurx.2006.05.006 · Cited by 46
Lynch, A. M., Mandava, N., Patnaik, J. L., Frazer-Abel, A. A., Wagner, B. D., Palestine, A. G., Mathias, M. T., Siringo, F. S., Cathcart, J. N., & Holers, V. M. (2020) · European Journal of Ophthalmology · doi:10.1177/1120672119857896 · Cited by 44
Radu, R. A., Hu, J., Jiang, Z., & Bok, D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.548669 · Cited by 44
Amini, M. A., Karbasi, A., Vahabirad, M., Khanaghaei, M., & Alizamir, A. (2023) · Chonnam Medical Journal · doi:10.4068/cmj.2023.59.3.143 · Cited by 57
“CFH 402H inhibits the extraction and transport of damaged lipids from the RPE layer, impairs the adjustment of CFH in preventing the cascade of conversion from C3 to C3b and eventually breaking from C3b, and thus increases AMD risk.(40) CFB and C2 are, respectively, triggers of alternative and classical pathways activ…”
BackgroundLibby, R. T., & Gould, D. B. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1399-9_46 · Cited by 47
“Genetic data support this contention, and loci containing genes encoding components of the alternate complement pathway are reproducibly associated with disease risk (Edwards et al. 2005; Hageman et al. 2005; Haines et al. 2005; Klein et al. 2005).”
ResultLee, M., Jones, T., Song, D., Jang, J., Jung, J. U., & Gao, S. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004412 · Cited by 49
Current Clinical Trials in Dry AMD and the Definition of Appropriate Clinical Outcome Measures
Yehoshua, Z., Rosenfeld, P. J., & Albini, T. A. (2011) · Seminars in Ophthalmology · doi:10.3109/08820538.2011.577132 · Cited by 50
Age- and Light-Dependent Development of Localised Retinal Atrophy in CCL2−/−CX3CR1GFP/GFP Mice
Chen, M., Hombrebueno, J. R., Luo, C., Penalva, R., Zhao, J., Colhoun, L., Pandi, S. P. S., Forrester, J. V., & Xu, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061381 · Cited by 42
Spencer, K. L., Olson, L. M., Schnetz‐Boutaud, N. C., Gallins, P. J., Agarwal, A., Iannaccone, A., Kritchevsky, S. B., García, M., Nalls, M. A., Newman, A. B., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017784 · Cited by 44
Armento, A., Schmidt, T. L., Sonntag, I., Merle, D. A., Jarboui, M. A., Kilger, E., Clark, S. J., & Ueffing, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168727 · Cited by 49
“One of the most common genetic risks, accounting for 50% of attributable risk for AMD, corresponds to a polymorphism in the complement factor H (CFH) gene that consists of a Tyr to His amino acid substitution at position 402 in the preprocessed factor H protein (FH: Position 384 in the mature FH protein) [21,22].”
BackgroundThe positives, protocols, and perils of genome‐wide association
Neale, B. M., & Purcell, S. (2008) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30747 · Cited by 47
“Both of these findings showed significant replication from a number of additional studies, and are almost certainly true associations [Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Arking et al., 2006; Maller et al., 2006; Post et al., 2007].”
BackgroundBatıoğlu, F., Oğuz, Y. G., Demirel, S., & Özmert, E. (2014) · Ophthalmic Research · doi:10.1159/000361077 · Cited by 47
Relevance of Complement Factor H–Related 1 (CFHR1) Genotypes in Age-Related Macular Degeneration
Martínez-Barricarte, R., Recalde, S., Fernández-Robredo, P., Millán, I., Olavarrieta, L., Viñuela, A., Pérez-Pérez, J., García-Layana, A., & Rodríguez de Córdoba, S. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-8709 · Cited by 43
Tuuminen, R., Uusitalo‐Järvinen, H., Aaltonen, V., Hautala, N. M., Kaipiainen, S., Laitamäki, N., Ollila, M., Rantanen, J., Välimäki, S., Sipilä, R., et al. (2017) · Acta Ophthalmologica · doi:10.1111/aos.13501 · Cited by 50
“• Hereditary predisposition Heredity accounts for 60% of cases of wAMD (Edwards et al. 2005; Haines et al. 2005; Klein et al. 2005; Kanda et al. 2007; Canter et al. 2008; Fritsche et al. 2013).”
BackgroundPeroxisome proliferator-activated receptor and age-related macular degeneration
Herzlich, A. A., Tuo, J., & Chan, C.-C. (2008) · PPAR Research · doi:10.1155/2008/389507 · Cited by 43
“AMD is a degenerative disease of the central portion of the retina (the macula) which results primarily in loss of central vision [6].”
Complement factor I: Regulatory nexus, driver of immunopathology, and therapeutic
Hallam, T. M., Sharp, S. J., Andreadi, A., & Kavanagh, D. (2023) · Immunobiology · doi:10.1016/j.imbio.2023.152410 · Cited by 46
Transcutaneous Electrical Retinal Stimulation Therapy for Age-Related Macular Degeneration
Shinoda, K., Imamura, Y., Matsuda, S., Seki, M., Uchida, A., Grossman, T., & Tsubota, K. (2006) · The Open Ophthalmology Journal · doi:10.2174/1874364100802010132 · Cited by 45
“Patients were excluded if they had any significant ocular disease other than subfoveal CNV or geographic atrophy, which affected visual acuity, a history of intraocular or laser surgery within 6 months, or if they had taken any medication used for AMD such as vitamins or lutein in the 6 months prior to the examination.”
Backgroundvan de Ven, J. P. H., Boon, C. J. F., Fauser, S., Hoefsloot, L. H., Smailhodzic, D., Schoenmaker-Koller, F. E., Klevering, B. J., Klaver, C. C. W., den Hollander, A. I., & Hoyng, C. B. (2012) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2012.265 · Cited by 49
“40 and may account for more than 50% of the attributable risk of AMD.(10-12) The CFH protein inhibits the alternative pathway by competing with CFB in binding to C3b, accelerating the decay of the alternative pathway C3 convertase and acting as a cofactor for the factor I–mediAuthor Affiliations: Departments of Ophtha…”
BackgroundFritsche, L. G., Freitag-Wolf, S., Bettecken, T., Meitinger, T., Keilhauer, C. N., Krawczak, M., & Weber, B. H. F. (2009) · Human Mutation · doi:10.1002/humu.20957 · Cited by 42
“At 1q31, strongly associated variants in the complement factor H gene (CFH; MIM# 134370) suggest an involvement of inflammation and the alternative pathway of the complement cascade in AMD pathogenesis [Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005].”
BackgroundMaximal conditional chi-square importance in random forests
Wang, M., Chen, X. '., & Zhang, H. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq038 · Cited by 47
“Successes of genome-wide association studies (GWAS) have demonstrated that single nucleotide polymorphisms (SNPs) can be used to identify genetic variants underlying complex diseases, such as age-related macular degeneration (AMD) and coronary artery disease (CAD) (Edwards et al., 2005; Haines et al., 2005; Helgadotti…”
BackgroundTreatment of Geographic Atrophy with Intravitreal Sirolimus
Gensler, G. R., Clemons, T. E., Domalpally, A., Danis, R. P., Blodi, B., Wells, J. A., Rauser, M., Hoskins, J. C., Hubbard, G. B., Elman, M. J., et al. (2017) · Ophthalmology Retina · doi:10.1016/j.oret.2017.08.015 · Cited by 45
C-Reactive Protein as a Therapeutic Target in Age-Related Macular Degeneration
Molins, B., Romero‐Vázquez, S., Fuentes‐Prior, P., Adán, A., & Dick, A. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00808 · Cited by 44
“The disease-causing molecular mechanisms remain unknown, although inflammatory processes have been implicated by the identification of AMD susceptibility genes encoding complement factors (5, 6) and by the presence of complement proteins in drusen, the hallmark deposits associated with”
BackgroundLow Immunogenicity and Immunosuppressive Properties of Human ESC- and iPSC-Derived Retinas
Yamasaki, S., Sugita, S., Horiuchi, M., Masuda, T., Fujii, S., Makabe, K., Kawasaki, A., Hayashi, T., Kuwahara, A., Kishino, A., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.02.021 · Cited by 43
“Scale bars, 500 mm process is involved in diseases, such as AMD and retinitis pigmentosa (Ambati et al., 2003; Edwards et al., 2005; Mandai et al., 2012; Wooff et al., 2019), as well as the transplantation procedure itself, these suppressive properties of hESC- and iPSC-retina are likely advantageous for successful ce…”
BackgroundMolecular biology of choroidal neovascularization.
Lu, M., & Adamis, A. P. (2006) · PubMed · doi:10.1016/j.ohc.2006.05.001 · Cited by 43
Munch, I. C., Ek, J., Kessel, L., Sander, B., Almind, G. J., Brøndum‐Nielsen, K., Linneberg, A. R., & Larsen, M. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4482 · Cited by 46
Edwards, A. O., Fridley, B. L., James, K. M., Sharma, A. K., Cunningham, J. M., & Tosakulwong, N. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003813 · Cited by 44
“Diagnosis was determined by review of fundus photographs as previously described [15].”
BackgroundMethodSelf-citationLeveziel, N., Zerbib, J., Richard, F., Querques, G., Morineau, G., Fremeaux-Bacchi, V., Coscas, G., Soubrane, G., Benlian, P., & Souied, E. H. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1540 · Cited by 43
Qin, S., & Rodrigues, G. A. (2008) · Journal of Inflammation Research · doi:10.2147/jir.s4354 · Cited by 46
The odd couple: A fresh look at autoimmunity and immunodeficiency
Mackay, I. R., Leskovsek, N. V., & Rose, N. R. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2010.06.008 · Cited by 42
Nguyen, Q. D., Agarwal, A. K., Rhoades, W. R., Hanout, M., Soliman, M. K., Sarwar, S., Sadiq, M. A., Sepah, Y. J., & Diana, V. (2015) · Clinical ophthalmology · doi:10.2147/opth.s74959 · Cited by 53
“The substitution of a histidine for tyrosine at position 402 of the CFH gene product may account for up to 50% of the attributable risk of AMD.(116) In addition to predicting the progression of the disease, genetic polymorphisms may also be associated with treatment response to anti-VEGF therapy.”
Tortajada, A., Pinto, S., Martínez-Ara, J., López‐Trascasa, M., Sánchez‐Corral, P., & de Córdoba, S. R. (2011) · Kidney International · doi:10.1038/ki.2011.291 · Cited by 45
Sakurada, Y., Kubota, T., Imasawa, M., Mabuchi, F., Tateno, Y., Tanabe, N., & Iijima, H. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2010.12.010 · Cited by 43
Interaction of Complement Factor H and Fibulin3 in Age-Related Macular Degeneration
Wyatt, M. K., Tsai, J.-Y., Mishra, S., Campos, M., Jaworski, C., Fariss, R. N., Bernstein, S. L., & Wistow, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068088 · Cited by 41
“Linkage analyses and candidate gene approaches have found significant association of AMD with sequence variants in the genes for complement factor H (CFH) [17,18,19,20] and the CFHrelated gene cluster [21,22] on human chromosome 1 and with the gene for the serine protease HTRA1 [23] or the neighboring LOC387715 [24] o…”
BackgroundFarwick, A., Dasch, B., Weber, B. H. F., Pauleikhoff, D., Stoll, M., & Hense, H.-W. (2009) · Eye · doi:10.1038/eye.2008.426 · Cited by 48
Genome-wide analysis of copy number variants in age-related macular degeneration
Meyer, K. J., Davis, L. K., Schindler, E. I., Beck, J. S., Rudd, D. S., Grundstad, A. J., Scheetz, T. E., Braun, T. A., Fingert, J. H., Alward, W. L. M., et al. (2010) · Human Genetics · doi:10.1007/s00439-010-0904-6 · Cited by 43
Diminishing Risk for Age-Related Macular Degeneration with Nutrition: A Current View
Schleicher, M. M., Weikel, K., Garber, C., & Taylor, A. (2013) · Nutrients · doi:10.3390/nu5072405 · Cited by 47
“the Complement Factor H gene [18–22].”
Haapasalo, K., Vuopio, J., Syrjänen, J., Suvilehto, J., Massinen, S., Karppelin, M., Järvelä, I. E., Meri, S., Kere, J., & Jokiranta, T. S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102545 · Cited by 51
Frazer‐Abel, A. A., Sepiashvili, L., Mbughuni, M. M., & Willrich, M. A. V. (2016) · Advances in clinical chemistry · doi:10.1016/bs.acc.2016.06.001 · Cited by 48
Liang, X. Y., Lai, T. Y. Y., Liu, D. T. L., Fan, A. H., Chen, L. J., Tam, P. O. S., Chiang, S. W. Y., Ng, T. K., Lam, D. S. C., & Pang, C. P. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8135 · Cited by 46
Rohrer, B., Coughlin, B. A., Bandyopadhyay, M., & Holers, V. M. (2012) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2011.0212 · Cited by 44
Oligochitosan polyplexes as carriers for retinal gene delivery
Puras, G., Sesma, J. Z., Díaz‐Tahoces, A., Avilés‐Trigueros, M., Fernández, E., & Pedraz, J. L. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.11.009 · Cited by 44
Age-Related Macular Degeneration: A Disease of Systemic or Local Complement Dysregulation?
Warwick, A., Khandhadia, S., Ennis, S., & Lotery, A. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041234 · Cited by 41
Loss of Self‐Control in the Complement System and Innate Autoreactivity
Meri, S. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1398.011 · Cited by 45
Age-Related Decline in VIP-Positive Parasympathetic Nerve Fibers in the Human Submacular Choroid
Jablonski, M. M., Iannaccone, A., Reynolds, D., Gallaher, P., Allen, S., Wang, X., & Reiner, A. J. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0972 · Cited by 44
Unraveling A Complex Genetic Disease: Age-related Macular Degeneration
Chamberlain, M., Baird, P. N., Dirani, M., & Guymer, R. H. (2006) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2006.08.003 · Cited by 48
Kim, I. K., Ji, F., Morrison, M. A., Adams, S. M., Zhang, Q., Lane, A. M., Capone, A., Dryja, T. P., Ott, J., Miller, J. W., et al. (2008) · PubMed · Cited by 43
The Complement Component 5 Gene and Age-Related Macular Degeneration
Baas, D. C., Ho, L., Ennis, S., Merriam, J. E., Tanck, M. W. T., Uitterlinden, A. G., de Jong, P. T. V. M., Cree, A. J., Griffiths, H., Rivadeneira, F., et al. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.08.032 · Cited by 48
Almeida, D. R. P., Zhang, L., Chin, E. K., Mullins, R. F., Küçükevcilioğlu, M., Critser, D. B., Milan Sonka, A., Stone, E. M., Folk, J. C., Abràmoff, M. D., et al. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2014.5168 · Cited by 44
Retinal pigment epithelial cells mitigate the effects of complement attack by endocytosis of C5b-9
Georgiannakis, A., Burgoyne, T., Lueck, K., Futter, C., Greenwood, J., & Moss, S. E. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500937 · Cited by 41
Molecular Genetic Mechanisms in Age-Related Macular Degeneration
Shughoury, A., Sevgi, D. D., & Ciulla, T. A. (2022) · Genes · doi:10.3390/genes13071233 · Cited by 48
Blaum, B. S., Deakin, J. A., Johansson, C. M., Herbert, A. P., Barlow, P. N., Lyon, M., & Uhrín, D. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1000517 · Cited by 42
Puche, N., Blanco-Garavito, R., Richard, F., Leveziel, N., Zerbib, J., Tilleul, J., Mimoun, G., Querques, G., Cohen, S. Y., & Souied, E. H. (2013) · Retina · doi:10.1097/iae.0b013e31827b6483 · Cited by 42
Dry age-related macular degeneration: A currently unmet clinical need
Girmens, J. (2012) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2012.v1.3.103 · Cited by 47
“Three initial studies have found an association between AMD and polymorphism of the CFH gene (Y402H) (18,21,22).”
BackgroundRegulation of Angiogenesis by Macrophages
Apte, R. S. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1399-9_2 · Cited by 41
Gene Ontology and KEGG Enrichment Analyses of Genes Related to Age-Related Macular Degeneration
Zhang, J., Xing, Z., Ma, M., Wang, N., Cai, Y., Chen, L., & Xu, X. (2014) · BioMed Research International · doi:10.1155/2014/450386 · Cited by 45
Nan, R., Farabella, I., Schumacher, F. F., Miller, A., Gor, J., Martin, A. C. R., Jones, D. T., Lengyel, I., & Perkins, S. J. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.03.006 · Cited by 42
Aredo, B., Li, T., Chen, X., Zhang, K., Wang, C. X.-Z., Gou, D., Zhao, B., He, Y.-G., & Ufret-Vincenty, R. L. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-16089 · Cited by 42
Zinc-induced Self-association of Complement C3b and Factor H
Nan, R., 南, 若., Tetchner, S., Rodriguez, E., Pao, P.-J., 鮑, 柏., Gor, J., Lengyel, I., & Perkins, S. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.476143 · Cited by 39
“Molecular mechanisms are suggested for the initial formation of sRPEds that lead to AMD as well as an explanation for the role of zinc in reducing the occurrence of developing advanced AMD in high risk patients (38, 39).”
BackgroundInfluentialAnalysis of plasma proteins that bind to glycosaminoglycans
Saito, A., & Munakata, H. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.10.015 · Cited by 40
Nakanishi, H., Yamashiro, K., Yamada, R., Gotoh, N., Hayashi, H., Nakata, I., Saito, M., Iida, T., Oishi, A., Kurimoto, Y., et al. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4948 · Cited by 41
Hadley, D., Orlin, A., Brown, G., Brucker, A. J., Ho, A. C., Regillo, C. D., Donoso, L. A., Tian, L., Kaderli, B., & Stambolian, D. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-3798 · Cited by 39
Nakata, I., Yamashiro, K., Yamada, R., Gotoh, N., Nakanishi, H., Hayashi, H., Akagi-Kurashige, Y., Tsujikawa, A., Otani, A., Saito, M., et al. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8468 · Cited by 41
Increased Neovascularization in Mice Lacking Tissue Inhibitor of Metalloproteinases-3
Ebrahem, Q., Qi, J. H., Sugimoto, M., Ali, M., Sears, J. E., Cutler, A., Khokha, R., Vasanji, A., & Anand‐Apte, B. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5899 · Cited by 43
Correction: Systemic Complement Activation in Age-Related Macular Degeneration
Scholl, H. P. N., Charbel Issa, P., Walier, M., Janzer, S., Pollok-Kopp, B., Börncke, F., Fritsche, L. G., Chong, N. V., Fimmers, R., Wienker, T., et al. (2008) · PLoS ONE · doi:10.1371/annotation/32b9bc31-ed6d-4d31-9ce0-480407017bad · Cited by 39
Metadata
- Authors
- Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A.
- Affiliations
- Boston University (US)
- Corresponding author
- Edwards, Albert O.
- Venue
- Science
- Published
- 2005-04-15
- Volume
- 308
- Issue
- 5720
- Pages
- 421-424
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W3145351529
- Cited by
- 2,449
- References
- 30
- Citations by year
- 2026: 24 · 2025: 41 · 2024: 51 · 2023: 48 · 2022: 78 · 2021: 105 · 2020: 73 · 2019: 52 · 2018: 81 · 2017: 65 · 2016: 89 · 2015: 120 · 2014: 141 · 2013: 146 · 2012: 166
- FWCI
- 195.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Eye Institute (EY014467, R01EY014467)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- age-related macular degeneration, complement factor H, CFH Y402H polymorphism, single nucleotide polymorphisms, genetic association, disease risk
- MeSH terms
- Aged, Alleles, Chromosomes, Human, Pair 1, Complement Activation, Female, Gene Frequency, Multigene Family, Genotype, Haplotypes, Histidine, Homozygote, Humans, Macular Degeneration, Male, Middle Aged, Risk Factors, Tyrosine, Genetic Variation, Linkage Disequilibrium, Case-Control Studies, Complement Factor H, Amino Acid Substitution, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.